Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.
Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression. BMC Musculoskelet Disord. 2015 Nov 26; 16:368.